Beranda › Alopecia Areata › Indiana
Uji klinis Alopecia Areata di Indiana
8 studi untuk Alopecia Areata mencari peserta di lokasi di Indiana.
Kota di Indiana
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07772492A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- Dawes Fretzin Clinical Research Group, Indianapolis
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Indiana University Health University Hospital /ID# 259827, Indianapolis
Menerima pesertaFase 3
Usia 12 hingga 63 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Menerima pesertaFase 3
Usia 6 hingga 14 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Options Research Group, West Lafayette
Menerima pesertaFase 1/2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Ds Research - Indiana, Clarksville
- Dawes Fretzin Clinical Research Group Llc., Indianapolis
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT07133308Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.